US Broker Ratings

Bio-Techne Corp (TECH): Investor Outlook Highlights 25.56% Potential Upside with Strong Buy Ratings

Bio-Techne Corp (NASDAQ: TECH) stands as a noteworthy player in the biotechnology industry, reflecting its robust market presence with a market capitalization of $9.38 billion. Based..

Incyte Corporation (INCY) Stock Analysis: A Biotech Giant with Growth Potential and 29.87% ROE

Incyte Corporation (NASDAQ: INCY) stands as a formidable player in the biotechnology sector, appealing to investors with its robust growth metrics and innovative portfolio. Headquartered in..

The Cigna Group (CI) Stock Analysis: Poised for a 14% Upside with Strong Buy Ratings

The Cigna Group (NYSE: CI), a formidable presence in the healthcare sector, stands out as a compelling investment opportunity. With a market cap of $77.85 billion,..

Glaukos Corporation (GKOS) Investor Outlook: Analyzing the 21% Potential Upside Amid Robust Revenue Growth

Glaukos Corporation (NYSE: GKOS) is making waves in the healthcare sector, specifically within the medical devices industry, with its innovative approach to treating ocular disorders. Based..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring the 32% Upside Potential

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, primarily operating within the diagnostics and research industry, has been a cornerstone for investors..

Agilent Technologies (A) Stock Analysis: Unpacking a 34.86% Potential Upside for Investors

Agilent Technologies, Inc. (NYSE: A), a stalwart in the healthcare sector and a key player within the diagnostics and research industry, has captured investor attention with..

Elanco Animal Health (ELAN) Stock Analysis: Evaluating Growth Potential in the Animal Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the niche of animal health. With its roots dating..

Gilead Sciences, Inc. (GILD): Investor Outlook on Robust Growth and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD), a stalwart in the healthcare sector, continues to capture investor attention with its formidable market presence and strategic collaborations that underpin..

McKesson Corporation (MCK) Stock Analysis: Navigating the Healthcare Sector with Strong Buy Ratings and Growth Potential

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare industry, particularly as a leading force in medical distribution. With a market capitalization of..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring the 11.08% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor interest with its robust portfolio of medical instruments and diagnostic..

Charles River Laboratories (CRL) Stock Analysis: Unpacking a Potential 33.71% Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 18.24% Potential Upside in the Biotech Arena

BeOne Medicines Ltd. (ONC), a key player in the biotechnology space, is capturing the attention of investors with its promising portfolio and robust growth metrics. Based..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 32.64% Upside Potential Amidst Market Challenges

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically within the medical devices industry, offers a compelling case for investors seeking opportunities amidst..

Encompass Health Corporation (EHC) Stock Analysis: A Robust 29.59% Upside Potential Ignites Investor Interest

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector, specifically within the medical care facilities industry, due to its substantial market presence and promising..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A Closer Look at Its 3.58% Dividend Yield and Growth Potential

For investors seeking exposure in the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents a compelling opportunity. As a prominent player in the drug manufacturing..

Qiagen N.V. (QGEN) Stock Analysis: Navigating the Diagnostics & Research Landscape with an 8.90% Potential Upside

Qiagen N.V. (QGEN), a prominent player in the diagnostics and research sector, continues to capture investor attention with its robust market presence and innovative solutions. Based..

Mettler-Toledo International (MTD) Stock Analysis: 10% Upside Potential in the Diagnostics & Research Sector

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the diagnostics and research industry, is capturing investor attention with its robust market presence and promising growth..

Humana Inc. (HUM) Stock Analysis: Navigating a 25% Potential Upside in the Healthcare Sector

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, presents a compelling opportunity for investors seeking growth and stability in a rapidly evolving industry...

Insmed Incorporated (INSM) Stock Analysis: An In-Depth Look at Its 44% Potential Upside

Investors eyeing the biotechnology sector may want to give Insmed Incorporated (NASDAQ: INSM) a closer look. With its focus on developing and commercializing therapies for serious..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds